Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiji Yoshimura

Showing results (11-20 of 297) with videos related to

Pageof 30
Sort By:
Ryoikibetsu Shokogun Shirizu|July 25, 2003
[Double depression]Kyoko Kaji, Reiji Yoshimura, Jun Nakamura
Therapeutic Advances in Psychopharmacology|August 15, 2022
Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depressionReiji Yoshimura, Naomichi Okamoto, Atsuko Ikenouchi
Psychiatria Danubina|April 15, 2023
Duloxetine Does not Affect Vascular Endothelial Growth Factor Plasma Levels in Patients with First-Episode, Drug-Naïve Major DepressionReiji Yoshimura, Naomichi Okamoto, Atsuko Ikenouchi
Psychiatria Danubina|October 18, 2022
Effects of Paroxetine on Plasma Levels of Vascular Endothelial Growth Factor in Patients with Major DepressionReiji- Yoshimura, Naomichi Okamoto, Atsuko Ikenouchi
Neuropsychiatric Disease and Treatment|November 6, 2019
Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolitesReiji Yoshimura, Taro Kishi, Nakao Iwata
Frontiers in Psychiatry|March 15, 2024
Editorial: Recent developments in neuroimaging in mood disordersKeita Watanabe, Jigar Jogia, Reiji Yoshimura
PCN Reports : Psychiatry and Clinical Neurosciences|August 4, 2025
Serum fetuin-A in major depressive disorder: Lower levels in patients, but no correlation with symptom severityAtsuko Ikenouchi, Rintaro Fujii, Reiji Yoshimura
PCN Reports : Psychiatry and Clinical Neurosciences|April 20, 2026
Clinical dilemma of mood stabilizer augmentation in treatment-resistant schizophrenia with residual phase: A case report of valproate-associated hypoglycemia and cytopenia, and subsequent lithium responseYoshiki Kasagi, Naomichi Okamoto, Reiji Yoshimura
Psychopharmacology Bulletin|November 7, 2022
Effect of Milnacipran on Plasma Level of Vascular Endothelial Growth Factor in Major DepressionReiji Yoshimura, Atsuko Ikenouchi, Naomichi Okamoto
Inorganic Chemistry|October 11, 2019
Dinuclear Pentacoordinated Organoyttrium Biphenolates as Initiators for the Synthesis of High-Molecular Weight Isotactic Poly(2-vinylpyridine)Masataka Oishi, Reiji Yoshimura, Nobuyoshi Nomura
Pageof 30

Showing results (11-20 of 297) with videos related to

Sort By:
Pageof 30
Ryoikibetsu Shokogun Shirizu|July 25, 2003
[Double depression]Kyoko Kaji, Reiji Yoshimura, Jun Nakamura
Therapeutic Advances in Psychopharmacology|August 15, 2022
Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depressionReiji Yoshimura, Naomichi Okamoto, Atsuko Ikenouchi
Psychiatria Danubina|April 15, 2023
Duloxetine Does not Affect Vascular Endothelial Growth Factor Plasma Levels in Patients with First-Episode, Drug-Naïve Major DepressionReiji Yoshimura, Naomichi Okamoto, Atsuko Ikenouchi
Psychiatria Danubina|October 18, 2022
Effects of Paroxetine on Plasma Levels of Vascular Endothelial Growth Factor in Patients with Major DepressionReiji- Yoshimura, Naomichi Okamoto, Atsuko Ikenouchi
Neuropsychiatric Disease and Treatment|November 6, 2019
Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolitesReiji Yoshimura, Taro Kishi, Nakao Iwata
Frontiers in Psychiatry|March 15, 2024
Editorial: Recent developments in neuroimaging in mood disordersKeita Watanabe, Jigar Jogia, Reiji Yoshimura
PCN Reports : Psychiatry and Clinical Neurosciences|August 4, 2025
Serum fetuin-A in major depressive disorder: Lower levels in patients, but no correlation with symptom severityAtsuko Ikenouchi, Rintaro Fujii, Reiji Yoshimura
PCN Reports : Psychiatry and Clinical Neurosciences|April 20, 2026
Clinical dilemma of mood stabilizer augmentation in treatment-resistant schizophrenia with residual phase: A case report of valproate-associated hypoglycemia and cytopenia, and subsequent lithium responseYoshiki Kasagi, Naomichi Okamoto, Reiji Yoshimura
Psychopharmacology Bulletin|November 7, 2022
Effect of Milnacipran on Plasma Level of Vascular Endothelial Growth Factor in Major DepressionReiji Yoshimura, Atsuko Ikenouchi, Naomichi Okamoto
Inorganic Chemistry|October 11, 2019
Dinuclear Pentacoordinated Organoyttrium Biphenolates as Initiators for the Synthesis of High-Molecular Weight Isotactic Poly(2-vinylpyridine)Masataka Oishi, Reiji Yoshimura, Nobuyoshi Nomura
Pageof 30